Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,400 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 5 February 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download: 

(PDF, 3MB, 197 pages)

 

Export 2449 results:
Author Title [ Type(Desc)] Year
Journal Article
C. Schneider, Adamcova, M., Jick, S. S., Schlagenhauf, P., Miller, M. K., Rhein, H. G., and Meier, C. R., Use of anti-malarial drugs and the risk of developing eye disorders, Travel Med Infect Dis, vol. 12, pp. 40-7, 2014.
J. Assayag, Pollak, M. N., and Azoulay, L., The use of aspirin and the risk of mortality in patients with prostate cancer, J Urol, vol. 193, pp. 1220-5, 2015.
L. Azoulay, Yin, H., Renoux, C., and Suissa, S., The use of atypical antipsychotics and the risk of breast cancer, Breast Cancer Res Treat, vol. 129, pp. 541-8, 2011.
R. G. Schlienger, Kraenzlin, M. E., Jick, S. S., and Meier, C. R., Use of beta-blockers and risk of fractures, Jama, vol. 292, pp. 1326-32, 2004.
F. de Vries, Souverein, P. C., Cooper, C., Leufkens, H. G., and van Staa, T. P., Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands, Calcif Tissue Int, vol. 80, pp. 69-75, 2007.
L. Azoulay, Soldera, S., Yin, H., and Bouganim, N., Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study, Epidemiology, vol. 27, pp. 594-601, 2016.
C. Seliger, Meier, C. R., Jick, S. S., Uhl, M., Bogdahn, U., Hau, P., and Leitzmann, M. F., Use of cardiac glycosides and risk of glioma, J Neurooncol, vol. 127, pp. 321-8, 2016.
A. Ruigomez, Rodriguez, L. A. Garcia, Cattaruzzi, C., Troncon, M. G., Agostinis, L., Wallander, M. A., and Johansson, S., Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes, Am J Epidemiol, vol. 150, pp. 476-81, 1999.
L. A. Garcia Rodriguez, Johansson, S., and L. Soriano, C., Use of clopidogrel and proton pump inhibitors after a serious acute coronary event: risk of coronary events and peptic ulcer bleeding, Thromb Haemost, vol. 110, pp. 1014-24, 2013.
Y. Vinogradova, Coupland, C., and Hippisley-Cox, J., Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases, Bmj, vol. 350, p. h2135, 2015.
T. P. van Staa, Abenhaim, L., and Cooper, C., Use of cyclical etidronate and prevention of non-vertebral fractures, Br J Rheumatol, vol. 37, pp. 87-94, 1998.
D. M. Carbonari, Saine, M. E., Newcomb, C. W., Blak, B., Roy, J. A., Haynes, K., Wood, J., Gallagher, A. M., Bhullar, H., Cardillo, S., Hennessy, S., Strom, B. L., and , Use of demographic and pharmacy data to identify patients included within both the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN), Pharmacoepidemiol Drug Saf, vol. 24, pp. 999-1003, 2015.
C. Meier, Brauchli, Y. B., Jick, S. S., Kraenzlin, M. E., and Meier, C. R., Use of depot medroxyprogesterone acetate and fracture risk, J Clin Endocrinol Metab, vol. 95, pp. 4909-16, 2010.
L. L. Lanza, McQuay, L. J., Rothman, K. J., Bone, H. G., Kaunitz, A. M., Harel, Z., Ataher, Q., Ross, D., Arena, P. L., and Wolter, K. D., Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture, Obstet Gynecol, vol. 121, pp. 593-600, 2013.
L. E. Derby, Myers, M. W., and Jick, H., Use of dexfenfluramine, fenfluramine and phentermine and the risk of stroke, Br J Clin Pharmacol, vol. 47, pp. 565-9, 1999.
A. Douros, Abrahami, D., Yin, H., Yu, O. H. Y., Renoux, C., Hudson, M., and Azoulay, L., Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes, Epidemiology, vol. 29, pp. 904-912, 2018.
J. H. Driessen, van Onzenoort, H. A., Henry, R. M., Lalmohamed, A., van den Bergh, J. P., Neef, C., Leufkens, H. G., and de Vries, F., Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture, Bone, vol. 68, pp. 124-30, 2014.
W. R. der Zanden, de Vries, F., Lalmohamed, A., Driessen, J. H., de Boer, A., Rohde, G., Neef, C., and C. Heijer, den, Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study, PLoS One, vol. 10, p. e0139367, 2015.
S. Bruderer, Bodmer, M., Jick, S. S., and Meier, C. R., Use of diuretics and risk of incident gout: a population-based case-control study, Arthritis Rheumatol, vol. 66, pp. 185-96, 2014.
V. Mandilaras, Bouganim, N., Yin, H., Asselah, J., and Azoulay, L., The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer, Br J Cancer, vol. 116, pp. 103-108, 2017.
F. Andersohn, Suissa, S., and Garbe, E., Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction, Circulation, vol. 113, pp. 1950-7, 2006.
S. Dial, Delaney, J. A., Barkun, A. N., and Suissa, S., Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease, Jama, vol. 294, pp. 2989-95, 2005.
M. Tuccori, Wu, J. W., Yin, H., Majdan, A., and Azoulay, L., The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes, Diabetes Care, vol. 38, pp. 2083-9, 2015.
C. R. Dormuth, Hemmelgarn, B. R., Paterson, J. M., James, M. T., Teare, G. F., Raymond, C. B., Lafrance, J. P., Levy, A., Garg, A. X., and Ernst, P., Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases, Bmj, vol. 346, p. f880, 2013.
J. Shawe, Mulnier, H., Nicholls, P., and Lawrenson, R., Use of hormonal contraceptive methods by women with diabetes, Prim Care Diabetes, vol. 2, pp. 195-9, 2008.
Y. Vinogradova, Coupland, C., and Hippisley-Cox, J., Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases, Bmj, vol. 364, p. k4810, 2019.
L. M. Knapen, de Jong, R. G., Driessen, J. H., Keulemans, Y. C., van Erp, N. P., De Bruin, M. L., Leufkens, H. G., Croes, S., and de Vries, F., Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study, Diabetes Obes Metab, vol. 19, pp. 401-411, 2017.
L. M. Knapen, van Dalem, J., Keulemans, Y. C., van Erp, N. P., Bazelier, M. T., De Bruin, M. L., Leufkens, H. G., Croes, S., Neef, C., de Vries, F., and Driessen, J. H., Use of incretin agents and risk of pancreatic cancer: a population-based cohort study, Diabetes Obes Metab, vol. 18, pp. 258-65, 2016.
T. P. van Staa, Leufkens, H. G., and Cooper, C., Use of inhaled corticosteroids and risk of fractures, J Bone Miner Res, vol. 16, pp. 581-8, 2001.
T. P. van Staa, Cooper, C., Leufkens, H. G., Lammers, J. W., and Suissa, S., The use of inhaled corticosteroids in the United Kingdom and the Netherlands, Respir Med, vol. 97, pp. 578-85, 2003.
R. Pradhan, Yin, H., Yu, O. H. Y., and Azoulay, L., The Use of Long-Acting Insulin Analogs and the Risk of Colorectal Cancer Among Patients with Type 2 Diabetes: A Population-Based Cohort Study, Drug Saf, 2019.
B. Smiechowski, Azoulay, L., Yin, H., Pollak, M. N., and Suissa, S., The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus, Cancer Epidemiol Biomarkers Prev, vol. 22, pp. 1877-83, 2013.
B. B. Smiechowski, Azoulay, L., Yin, H., Pollak, M. N., and Suissa, S., The use of metformin and the incidence of lung cancer in patients with type 2 diabetes, Diabetes Care, vol. 36, pp. 124-9, 2013.
M. Bodmer, Becker, C., Meier, C., Jick, S. S., and Meier, C. R., Use of metformin and the risk of ovarian cancer: a case-control analysis, Gynecol Oncol, vol. 123, pp. 200-4, 2011.
M. Bodmer, Becker, C., Meier, C., Jick, S. S., and Meier, C. R., Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis, Cancer Epidemiol Biomarkers Prev, vol. 21, pp. 280-6, 2012.
J. Watson, Jones, H. E., Banks, J., Whiting, P., Salisbury, C., and Hamilton, W., Use of multiple inflammatory marker tests in primary care: using Clinical Practice Research Datalink to evaluate accuracy, Br J Gen Pract, vol. 69, pp. e462-e469, 2019.
S. J. Roberts and Bateman, D. N., The use of nitrates, calcium channel blockers and ACE inhibitors in primary care in the Northern Region: a pharmacoepidemiological study, Br J Clin Pharmacol, vol. 38, pp. 489-97, 1994.
T. P. van Staa, Leufkens, H. G., and Cooper, C., Use of nonsteroidal anti-inflammatory drugs and risk of fractures, Bone, vol. 27, pp. 563-8, 2000.
R. G. Schlienger, Jick, H., and Meier, C. R., Use of nonsteroidal anti-inflammatory drugs and the risk of first-time acute myocardial infarction, Br J Clin Pharmacol, vol. 54, pp. 327-32, 2002.
A. Mitchell, Welsh, T. J., Watson, M. C., Snowball, J., and McGrogan, A., Use of oral anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a cohort study using the Clinical Practice Research Datalink (CPRD) database, BMJ Open, vol. 9, p. e032646, 2019.
J. Gorricho, Garjon, J., Alonso, A., Celaya, M. C., Saiz, L. C., Erviti, J., and Lopez, A., Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study, Br J Clin Pharmacol, vol. 83, pp. 2034-2044, 2017.
T. P. van Staa, Leufkens, H. G., Abenhaim, L., Zhang, B., and Cooper, C., Use of oral corticosteroids and risk of fractures, J Bone Miner Res, vol. 15, pp. 993-1000, 2000.
T. P. van Staa, Leufkens, H. G., Abenhaim, L., Begaud, B., Zhang, B., and Cooper, C., Use of oral corticosteroids in the United Kingdom, Qjm, vol. 93, pp. 105-11, 2000.
P. C. Souverein, Berard, A., van Staa, T. P., Cooper, C., Egberts, A. C., Leufkens, H. G., and Walker, B. R., Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study, Heart, vol. 90, pp. 859-65, 2004.
A. Keyany, Nielen, J. T. H., Souverein, P. C., de Vries, F., and van den Bemt, B., Use of parenteral glucocorticoids and the risk of new onset type 2 diabetes mellitus: A case-control study, Diabetes Res Clin Pract, vol. 139, pp. 100-106, 2018.
L. Azoulay, Yin, H., Filion, K. B., Assayag, J., Majdan, A., Pollak, M. N., and Suissa, S., The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study, Bmj, vol. 344, p. e3645, 2012.
P. Tammes, Sartini, C., Preston, I., Hay, A. D., Lasserson, D., and Morris, R. W., Use of primary care data to predict those most vulnerable to cold weather: a case-crossover analysis, Br J Gen Pract, vol. 68, pp. e146-e156, 2018.
R. L. Tannen, Weiner, M. G., and Xie, D., Use of primary care electronic medical record database in drug efficacy research on cardiovascular outcomes: comparison of database and randomised controlled trial findings, Bmj, vol. 338, p. b81, 2009.
A. Tran-Duy, Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., Hoes, A. W., de Vries, F., and de Boer, A., Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study, J Intern Med, 2018.
A. Tran-Duy, Connell, N. J., Vanmolkot, F. H., Souverein, P. C., de Wit, N. J., Stehouwer, C. D. A., Hoes, A. W., de Vries, F., and de Boer, A., Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study, J Intern Med, vol. 285, pp. 205-214, 2019.
[Page last reviewed 5 February 2020]